CTOs on the Move

MD Revolution

www.mdrevolution.com

 
MD Revolution harnesses the power of digital health technology to predict, prevent, and reverse chronic disease – and lower healthcare costs. MD Revolution is a transformational digital health provider that delivers a proven population health management service. Our SaaS solution, RevUp, has revolutionized the approach to behavior change for lifestyle diseases including diabetes, obesity, and heart disease. Participants on RevUp receive actionable feedback based on personal health data gathered from wearables and apps. Predictive analytics drive real-time identification of individuals that will or will not achieve desired health outcomes, thereby allowing clinicians and health coaches to focus on participants who require more ...
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million
  • www.mdrevolution.com
  • 9191 Towne Centre Drive, Suite 510
    San Diego, CA USA 92122
  • Phone: 858.847.5064

Executives

Name Title Contact Details

Funding

MD Revolution raised $23M on 12/07/2015

Similar Companies

FLAVORx, Inc.

FLAVORx, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bethesda, MD. To find more information about FLAVORx, Inc., please visit www.flavorx.com

Susque-View Home and Health Ctr

Susque-View Home and Health Ctr is a Lock Haven, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrated Prescription Solutions

Integrated Prescription Solutions is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

American Clinical Research Services

American Clinical Research Services is a company that provides clinical research services.